1 / 18

The process of ethical approval

The process of ethical approval. Helena Prady Senior Research Nurse. Objectives. Definitions Sponsor Chief Investigator Principal Investigator The process of approvals Regulatory body Ethics R&D O ther Other considerations for set up of trials. Sponsor.

nadda
Download Presentation

The process of ethical approval

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. The process of ethical approval Helena Prady Senior Research Nurse

  2. Objectives • Definitions • Sponsor • Chief Investigator • Principal Investigator • The process of approvals • Regulatory body • Ethics • R&D • Other • Other considerations for set up of trials

  3. Sponsor "sponsor" means, in relation to a clinical trial, the person who takes responsibility for the initiation, management and financing (or arranging the financing) of that trial. The Medicines for Human Use (Clinical Trials) Regulations 2004 • Often a commercial company eg Actelion • Can be the Chief Investigator’s employer Medicines for Children Research Network

  4. Chief Investigator (CI) The authorised health care professional….who takes primary responsibility for the conduct of the trial. • Undertakes many duties delegated by the sponsor • Usually one CI for each trial but if international, there will be a CI in each country Medicines for Children Research Network

  5. Principal Investigator (PI) The investigator responsible for the research at a site • There should be one PI for each research site. • In the case of a single-site study, the CI and the PI will normally be the same person. Medicines for Children Research Network

  6. ‘Approvals’ needed • Medicines for Human Use Regulatory Authority • Only is drug or device trial • Research Ethics Committee • Main • Local • Local R&D approval • May be Trust, University, PCT • Others • Depend on type of research

  7. The Integrated Research Application System Is a single system for applying for the permissions and approvals for health and social care / community care research in the UK • Administration of Radioactive Substances Advisory Committee (ARSAC) • Gene Therapy Advisory Committee (GTAC) • Medicines and Healthcare products Regulatory Agency (MHRA) • Ministry of Justice • NHS / HSC R&D offices • NRES/ NHS / HSC Research Ethics Committees • National Information Governance Board (NIGB) • Social Care Research Ethics Committee

  8. Medicines for Human use Regulatory Authority • UK regulatory body • Their approval is a Clinical Trials Authorisation (CTA) • The Sponsor applies for this • Only needed for clinical trials of Investigational Medicinal Product or devices • 30 calendar day timeline from receipt of valid application

  9. Medicines for Human use Regulatory Authority • Before giving authorisation, the MHRA consider the science of the research: • What is the question • Has it been researched before • Animal + human • What adverse events were reported • Is the protocol relevant • Are the patients appropriate • Peer reviewed • How drug to be manufactured • Statistics • + + +

  10. Main Research Ethics Committee • The Sponsor or Chief Investigator applies to MREC • Documents considered include • Protocol • Patient information sheets and consent forms • Other information for patients • GP letter • CV and training of Principal Investigator • Their approval is ‘favourable opinion’ • 60 calendar day timeline from receipt of valid application

  11. Main Research Ethics Committee MREC consider the ethicalness of the trial • What type of patient is it? • Paediatrics/ vulnerable adult • What are they required to do? • Amount of blood testing • Number of visits • Invasive/ non routine assessments • Consent process – including recruitment • Patient information leaflets etc • Age related understandable • ? To be translated • Travel expenses to be paid?

  12. Local Research Ethics Committee • Consider local issues • Suitability of site • Suitability of researchers • Some studies eg qualitative, may be exempt from LREC approval (but always require R&D)

  13. Trust R&D • National Institute for Health Research (NIHR) Coordinated System for gaining NHS Permission (CSP). • This is for NIHR portfolio studies • Reduces the need for repeat checks of eg MHRA, MREC approvals • Once one site has done the checks, they are on the system so others don’t have to do again • They give ‘approval’.

  14. Trust R&D • R&D consider • Suitability of researchers • Whether other approvals in place • this is now done by CSP • Costs and agreements • Whether any impact on services • Pharmacy – during trial and after • Labs / radiology • Whether these patients over-researched

  15. Clinical Trials Agreement (CTA!) • model Clinical Trial Agreement (mCTA) is contract between Sponsor and site (+/-university) commonly known as Sponsor agreement • Responsibilities etc • Costings and budget • This contract has to go from sponsor to R&D, agreed, sent back for original signature and then back to site for original signature. • This may well be the cause of delays as lots of negotiation often needed and lots of stages

  16. Other considerations • Recruiting necessary staff – eg research nurse • Training of site staff • May be trial specific or general • Collection of CVs, training certificates for assessors • Delegation of duties clarified • Other departments ready • Pharmacy / labs / radiology

  17. Other considerations • How are you going to recruit patients • Where are they? • Who can make first contact with them (data protection) • Ensuring systems in place • Standard Operating Procedures • Finance issues arranged • Payment to other departments • Travel/accommodation reimbursement • Storage of equipment, documentation • Enough space • Lockable

  18. Thank you • Hope this has helped you to appreciate the stages of preparation involved in setting up studies at site • There may be more stages and issues for different types of research and patients • I am really sorry not to have been here.

More Related